Beijing [China], January 27 (ANI): Moderna, an American pharmaceutical and biotechnology company based in Cambridge on Wednesday (local time) announced that it has begun clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.